Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In Silico Experimentation

Cancer with all its more than 200 variants continues to be a major health problem around the world with nearly 10 million deaths recorded in 2020, and leukemia accounted for more than 300,000 cases according to the Global Cancer Observatory. Although new treatment strategies are currently being deve...

Full description

Bibliographic Details
Main Authors: Paul A. Valle, Raul Garrido, Yolocuauhtli Salazar, Luis N. Coria, Corina Plata
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/7/1396
_version_ 1797444345572360192
author Paul A. Valle
Raul Garrido
Yolocuauhtli Salazar
Luis N. Coria
Corina Plata
author_facet Paul A. Valle
Raul Garrido
Yolocuauhtli Salazar
Luis N. Coria
Corina Plata
author_sort Paul A. Valle
collection DOAJ
description Cancer with all its more than 200 variants continues to be a major health problem around the world with nearly 10 million deaths recorded in 2020, and leukemia accounted for more than 300,000 cases according to the Global Cancer Observatory. Although new treatment strategies are currently being developed in several ongoing clinical trials, the high complexity of cancer evolution and its survival mechanisms remain as an open problem that needs to be addressed to further enhanced the application of therapies. In this work, we aim to explore cancer growth, particularly chronic lymphocytic leukemia, under the combined application of CAR-T cells and chlorambucil as a nonlinear dynamical system in the form of first-order Ordinary Differential Equations. Therefore, by means of nonlinear theories, sufficient conditions are established for the eradication of leukemia cells, as well as necessary conditions for the long-term persistence of both CAR-T and cancer cells. Persistence conditions are important in treatment protocol design as these provide a threshold below which the dose will not be enough to produce a cytotoxic effect in the tumour population. In silico experimentations allowed us to design therapy administration protocols to ensure the complete eradication of leukemia cells in the system under study when considering only the infusion of CAR-T cells and for the combined application of chemoimmunotherapy. All results are illustrated through numerical simulations. Further, equations to estimate cytotoxicity of chlorambucil and CAR-T cells to leukemia cancer cells were formulated and thoroughly discussed with a <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mn>95</mn><mo>%</mo></mrow></semantics></math></inline-formula> confidence interval for the parameters involved in each formula.
first_indexed 2024-03-09T13:11:19Z
format Article
id doaj.art-2047f2be5b7e47f08f5e3621567e04c1
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T13:11:19Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-2047f2be5b7e47f08f5e3621567e04c12023-11-30T21:41:39ZengMDPI AGPharmaceutics1999-49232022-07-01147139610.3390/pharmaceutics14071396Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In Silico ExperimentationPaul A. Valle0Raul Garrido1Yolocuauhtli Salazar2Luis N. Coria3Corina Plata4Postgraduate Program in Engineering Sciences, BioMath Research Group, Tecnológico Nacional de México/IT Tijuana, Blvd. Alberto Limón Padilla s/n, Tijuana 22454, MexicoPostgraduate Program in Engineering Sciences, BioMath Research Group, Tecnológico Nacional de México/IT Tijuana, Blvd. Alberto Limón Padilla s/n, Tijuana 22454, MexicoPostgraduate Program in Engineering, Tecnológico Nacional de México/IT Durango, Blvd. Felipe Pescador 1830 ote., Durango 34080, MexicoPostgraduate Program in Engineering Sciences, BioMath Research Group, Tecnológico Nacional de México/IT Tijuana, Blvd. Alberto Limón Padilla s/n, Tijuana 22454, MexicoPostgraduate Program in Engineering Sciences, BioMath Research Group, Tecnológico Nacional de México/IT Tijuana, Blvd. Alberto Limón Padilla s/n, Tijuana 22454, MexicoCancer with all its more than 200 variants continues to be a major health problem around the world with nearly 10 million deaths recorded in 2020, and leukemia accounted for more than 300,000 cases according to the Global Cancer Observatory. Although new treatment strategies are currently being developed in several ongoing clinical trials, the high complexity of cancer evolution and its survival mechanisms remain as an open problem that needs to be addressed to further enhanced the application of therapies. In this work, we aim to explore cancer growth, particularly chronic lymphocytic leukemia, under the combined application of CAR-T cells and chlorambucil as a nonlinear dynamical system in the form of first-order Ordinary Differential Equations. Therefore, by means of nonlinear theories, sufficient conditions are established for the eradication of leukemia cells, as well as necessary conditions for the long-term persistence of both CAR-T and cancer cells. Persistence conditions are important in treatment protocol design as these provide a threshold below which the dose will not be enough to produce a cytotoxic effect in the tumour population. In silico experimentations allowed us to design therapy administration protocols to ensure the complete eradication of leukemia cells in the system under study when considering only the infusion of CAR-T cells and for the combined application of chemoimmunotherapy. All results are illustrated through numerical simulations. Further, equations to estimate cytotoxicity of chlorambucil and CAR-T cells to leukemia cancer cells were formulated and thoroughly discussed with a <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mn>95</mn><mo>%</mo></mrow></semantics></math></inline-formula> confidence interval for the parameters involved in each formula.https://www.mdpi.com/1999-4923/14/7/1396cancerCAR-T cellschlorambucilcytotoxicityin silicoleukemia
spellingShingle Paul A. Valle
Raul Garrido
Yolocuauhtli Salazar
Luis N. Coria
Corina Plata
Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In Silico Experimentation
Pharmaceutics
cancer
CAR-T cells
chlorambucil
cytotoxicity
in silico
leukemia
title Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In Silico Experimentation
title_full Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In Silico Experimentation
title_fullStr Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In Silico Experimentation
title_full_unstemmed Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In Silico Experimentation
title_short Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In Silico Experimentation
title_sort chemoimmunotherapy administration protocol design for the treatment of leukemia through mathematical modeling and in silico experimentation
topic cancer
CAR-T cells
chlorambucil
cytotoxicity
in silico
leukemia
url https://www.mdpi.com/1999-4923/14/7/1396
work_keys_str_mv AT paulavalle chemoimmunotherapyadministrationprotocoldesignforthetreatmentofleukemiathroughmathematicalmodelingandinsilicoexperimentation
AT raulgarrido chemoimmunotherapyadministrationprotocoldesignforthetreatmentofleukemiathroughmathematicalmodelingandinsilicoexperimentation
AT yolocuauhtlisalazar chemoimmunotherapyadministrationprotocoldesignforthetreatmentofleukemiathroughmathematicalmodelingandinsilicoexperimentation
AT luisncoria chemoimmunotherapyadministrationprotocoldesignforthetreatmentofleukemiathroughmathematicalmodelingandinsilicoexperimentation
AT corinaplata chemoimmunotherapyadministrationprotocoldesignforthetreatmentofleukemiathroughmathematicalmodelingandinsilicoexperimentation